Sally Susman

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
15 7% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Corporate Affairs Officer, Executive Vice President Pfizer Inc Jan. 1, 2019 -
Executive Vice President - Corporate Affairs Pfizer Inc Dec. 1, 2010 - Dec. 1, 2018
Sally Susman's trades of UL Solutions Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-18 2024-04-16
B Purchase
28,140 +49.3%
197.72
US$3,156,516 		28,140 +49.3% 197.72 US$3,156,516
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
83,124 +35.0%
147.20
US$2,340,649 		83,124 +35.0% 147.20 US$2,340,649
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
90,318 -38.9%
337.54
US$553,451 		90,318 -38.9% 337.54 US$553,451
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
3,700 -2.9%
54.55
US$201,835 		3,700 -2.9% 54.55 US$201,835
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
2,279 -1.8%
54.45
US$124,092 		2,279 -1.8% 54.45 US$124,092
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,130 -0.9%
54.65
US$61,754 		1,130 -0.9% 54.65 US$61,754
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
901 -0.7%
54.56
US$49,159 		901 -0.7% 54.56 US$49,159
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
800 -0.6%
54.47
US$43,576 		800 -0.6% 54.47 US$43,576
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
700 -0.5%
54.49
US$38,143 		700 -0.5% 54.49 US$38,143
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
700 -0.5%
54.50
US$38,150 		700 -0.5% 54.50 US$38,150
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
400 -0.3%
54.51
US$21,804 		400 -0.3% 54.51 US$21,804
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
399 -0.3%
54.53
US$21,757 		399 -0.3% 54.53 US$21,757
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
250 -0.2%
54.57
US$13,642 		250 -0.2% 54.57 US$13,642
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
101 -0.1%
54.48
US$5,502 		101 -0.1% 54.48 US$5,502
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
58 -0.0%
54.43
US$3,157 		58 -0.0% 54.43 US$3,157
2020-11-10 2020-11-09
US Pfizer Inc (PFE)
PlS Planned sale
43,662 -28.8%
41.94
US$1,831,184 		43,662 -28.8% 41.94 US$1,831,184
2020-04-03 2020-04-03
GB Norcros PLC (NXR)
B Purchase
200,000
1.21
£242,000 		200,000 1.21 £242,000
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
6,348 -5.5%
42.98
US$272,837 		6,348 -5.5% 42.98 US$272,837
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
4,496 -3.8%
43.03
US$193,463 		4,496 -3.8% 43.03 US$193,463
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
4,289 -3.5%
43.50
US$186,572 		4,289 -3.5% 43.50 US$186,572
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
4,116 -3.2%
43.00
US$176,988 		4,116 -3.2% 43.00 US$176,988
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
3,573 -2.7%
42.92
US$153,353 		3,573 -2.7% 42.92 US$153,353
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
3,260 -2.4%
43.01
US$140,213 		3,260 -2.4% 43.01 US$140,213
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,782 -2.0%
42.91
US$119,376 		2,782 -2.0% 42.91 US$119,376
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,657 -1.9%
42.99
US$114,224 		2,657 -1.9% 42.99 US$114,224
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,442 -1.7%
42.97
US$104,933 		2,442 -1.7% 42.97 US$104,933
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,233 -1.5%
43.05
US$96,131 		2,233 -1.5% 43.05 US$96,131
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,228 -1.5%
43.45
US$96,807 		2,228 -1.5% 43.45 US$96,807
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,200 -1.5%
42.95
US$94,490 		2,200 -1.5% 42.95 US$94,490
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,147 -1.4%
42.93
US$92,171 		2,147 -1.4% 42.93 US$92,171
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
2,078 -1.4%
42.96
US$89,271 		2,078 -1.4% 42.96 US$89,271
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,933 -1.2%
43.42
US$83,931 		1,933 -1.2% 43.42 US$83,931
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,800 -1.1%
43.06
US$77,508 		1,800 -1.1% 43.06 US$77,508
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,641 -1.0%
43.49
US$71,367 		1,641 -1.0% 43.49 US$71,367
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,471 -0.9%
43.35
US$63,768 		1,471 -0.9% 43.35 US$63,768
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,401 -0.9%
43.51
US$60,958 		1,401 -0.9% 43.51 US$60,958
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,400 -0.9%
43.36
US$60,704 		1,400 -0.9% 43.36 US$60,704
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,386 -0.8%
43.48
US$60,263 		1,386 -0.8% 43.48 US$60,263
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,324 -0.8%
43.53
US$57,634 		1,324 -0.8% 43.53 US$57,634
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,186 -0.7%
43.54
US$51,638 		1,186 -0.7% 43.54 US$51,638
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
1,100 -0.7%
43.44
US$47,784 		1,100 -0.7% 43.44 US$47,784
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
985 -0.6%
43.02
US$42,375 		985 -0.6% 43.02 US$42,375
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
943 -0.6%
42.94
US$40,492 		943 -0.6% 42.94 US$40,492
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
927 -0.5%
43.47
US$40,297 		927 -0.5% 43.47 US$40,297
2019-03-06 2019-03-04
US Pfizer Inc (PFE)
PlS Planned sale
852 -0.5%
43.24
US$36,840 		852 -0.5% 43.24 US$36,840